Table 4 Prevalence (%) of patients experiencing ≥1 exacerbation and health services utilization among COPD patients in the commercial and Medicare datasets*
Parameter, | Commercial dataset (n = 42,565) | Medicare dataset (n = 8,507) |
|---|---|---|
Exacerbations | ||
Inpatient hospitalization | 13.9 | 19.4 |
ER visit exacerbation | 4.5 | 4.5 |
Ambulatory exacerbations, with qualifying diagnosis | 35.6 | 27.6 |
Ambulatory exacerbations supported by qualifying drug therapy | 49.6 | 34.0 |
Total exacerbations (any of the above types) | 70.6 | 61.0 |
Health services | ||
Hospitalization (any reason) | 39.2 | 52.9 |
Office consultation/visit | 98.7 | 96.4 |
Standard chest X-rays | 73.1 | 74.8 |
Electrocardiogram | 56.9 | 68.9 |
Pulmonary function testing | 40.0 | 33.2 |
Respiratory-related equipment/supplies | 26.0 | 35.7 |
Heart echo exam | 25.8 | 40.1 |
Chest/thorax CT/MRI | 23.6 | 26.6 |
Cardiovascular stress test | 19.2 | 19.2 |
Respiratory/inhalation therapy | 19.1 | 14.9 |
Cardiac catheterization/coronary angiography | 9.3 | 8.0 |
Bone density study | 7.8 | 7.6 |
Sleep studies | 5.4 | 2.0 |
Disease management program | 4.1 | 0 |
Bronchoscopy | 3.9 | 3.6 |